Poniard Pharmaceuticals, Inc. (PARD)
Stock Price: $0.0700 USD
0.0000 (0.00%)
Updated Apr 13, 2021 9:30 AM EDT - Market closed
Market Cap | 434,756 |
Revenue (ttm) | n/a |
Net Income (ttm) | n/a |
Shares Out | 1.50M |
EPS (ttm) | -3.79 |
PE Ratio | n/a |
Forward PE | n/a |
Dividend | n/a |
Dividend Yield | n/a |
Trading Day | April 13 |
Last Price | $0.0700 |
Previous Close | $0.0700 |
Change ($) | 0.0000 |
Change (%) | 0.00% |
Day's Open | 0.0700 |
Day's Range | 0.0700 - 0.0700 |
Day's Volume | 0 |
52-Week Range | 0.0300 - 0.1200 |
News
There are no news available yet.
About PARD
Poniard Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of cancer therapeutics. Its lead platform product candidate includes Picoplatin, a platinum-based cancer therapy to treat multiple cancer indications, including small cell lung, colorectal, prostate, and ovarian cancers. The company has conducted a pivotal Phase III SPEAR trial of Picoplatin in the second-line treatment of patients with small cell lung cancer; Phase II trials evaluating picoplatin as a first-line treatment of metastatic ... [Read more...]
Industry Biotechnology | IPO Date Aug 11, 1988 |
Stock Exchange OTCMKTS | Ticker Symbol PARD |